Výsledky vyhledávání - "Mark G Carmichael"

Next-Generation Gene Sequencing Differentiates Hypoplastic Myelodysplastic Syndrome from Aplastic Anemia

Autor: Jeffrey L, Lew, Joshua L, Fenderson, Mark G, Carmichael

Publikováno v: Hawai'i journal of medicinepublic health : a journal of Asia Pacific MedicinePublic Health. 76(11 Suppl 2)

Hypoplastic Myelodysplastic Syndrome (h-MDS) comprises 15% of all MDS and has traditionally been difficult to distinguish from aplastic anemia (AA) by current testing. Accurate differentiation is important because treatment and prognosis differ. Sinc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::17c4068c62a5950931dd37a40662de33
https://pubmed.ncbi.nlm.nih.gov/29164009

Zobrazit plný text záznamu

Atypical Histiocyte-Rich Sweet's Syndrome

Autor: Mark G Carmichael, Sharon Chi, Sunghun Cho, Marcia A. Leung, Michael C. Royer

Publikováno v: Case Reports in Dermatological Medicine
Case Reports in Dermatological Medicine, Vol 2017 (2017)

Sweet’s Syndrome is a rare neutrophilic dermatosis thought to be a result of immune dysregulation occurring in the setting of drug exposure, recent infection, pregnancy, and underlying malignancy or idiopathic with specific and widely accepted diag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b68576b4d47582ef1916106210d9b70
http://europepmc.org/articles/PMC5664242

Zobrazit plný text záznamu

Concurrent Systemic Chemoimmunotherapy and Sofosbuvir-Based Antiviral Treatment in a Hepatitis C Virus-Infected Patient With Diffuse Large B-Cell Lymphoma

Autor: Phalgoon A. Shah, Tomas Ferguson, Mark G. Carmichael, Evan C. Ewers

Publikováno v: Open Forum Infectious Diseases

Hepatitis C virus (HCV) infection is associated with the development of non-Hodgkin lymphomas. For aggressive lymphomas, such as diffuse large B-cell lymphoma (DLBCL), treatment of HCV infection is typically deferred in treatment-naive patients until

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68ee1a47cef1cd89a8d1661d155ae253
https://pubmed.ncbi.nlm.nih.gov/28018926

Zobrazit plný text záznamu

Comparison of different HER2/neuvaccines in adjuvant breast cancer trials: implications for dosing of peptide vaccines

Autor: Guy T. Clifton, Jarrod P. Holmes, Jeremy D. Gates, Sathibalan Ponniah, George E. Peoples, Alan K. Sears, Elizabeth A. Mittendorf, Linda C. Benavides, Mark G. Carmichael, Kevin S. Clive

Publikováno v: Expert Review of Vaccines. 10:201-210

We have performed multiple adjuvant clinical trials using immunogenic peptides from the HER2/neu protein (AE37/E75/GP2) plus (GM-CSF) given intradermally to breast cancer patients. Four trials were performed with similar dose-escalation design with i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0e5d4a8554eedfbb0fca8c18e417ea1
https://doi.org/10.1586/erv.10.167

Zobrazit plný text záznamu

Longterm Followup Assessment of a HER2/ neu Peptide (E75) Vaccine for Prevention of Recurrence in High-Risk Prostate Cancer Patients

Autor: George E. Peoples, Jeremy D. Gates, Mark G. Carmichael, C. G. Ioannides, Craig H. Robson, Matthew T. Hueman, Linda C. Benavides, Michael M. Woll, Sathibalan Ponniah, Jarrod P. Holmes, David G. McLeod

Publikováno v: Journal of the American College of Surgeons. 208:193-201

Background E75 is an immunogenic peptide from the HER2/ neu protein that is expressed in prostate cancer. High-risk prostate cancer (HRPC) patients demonstrating varying levels of HER2/ neu expression were vaccinated with E75 peptide plus granulocyte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99cbac7e1d2a4311698a128a94427885
https://doi.org/10.1016/j.jamcollsurg.2008.10.018

Zobrazit plný text záznamu

Results of the First Phase I Clinical Trial of the Novel Ii-Key Hybrid Preventive HER-2/neuPeptide (AE37) Vaccine

Autor: Elizabeth A. Mittendorf, Matthew T. Hueman, George E. Peoples, Asna Amin, Eric von Hofe, Jarrod P. Holmes, Linda C. Benavides, James L. Murray, Dianna Craig, Mark G. Carmichael, Jeremy D. Gates, Sathibalan Ponniah

Publikováno v: Journal of Clinical Oncology. 26:3426-3433

PurposeHER-2/neu is overexpressed in breast cancer and is the source of immunogenic peptides. CD4+T-helper peptides for HER-2/neu are being evaluated in vaccine trials. The addition of Ii-Key, a four–amino-acid LRMK modification, increases vaccine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddcdf0c0a06fe7e3995c08d5262965e4
https://doi.org/10.1200/jco.2007.15.7842

Zobrazit plný text záznamu

Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02

Autor: Alex Stojadinovic, Catherine E. Storrer, George E. Peoples, Elizabeth A. Mittendorf, Matthew T. Hueman, Dianna Craig, Jarrod P. Holmes, Linda C. Benavides, Jeremy D. Gates, Asna Amin, Mark G. Carmichael, Sathibalan Ponniah, Yusuf Jama

Publikováno v: Cancer Immunology, Immunotherapy. 57:1817-1825

E75, a HER2/neu immunogenic peptide, is expressed in breast cancer (BCa). We have performed clinical trials of E75 + GM-CSF vaccine in disease-free, node-positive and node-negative BCa patients at high recurrence risk and recurrences were noted in bo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7603dd31a8a5e0d9477f2f714efac771
https://doi.org/10.1007/s00262-008-0509-2

Zobrazit plný text záznamu

A 59-Year-Old Woman with Tuberculous Meningitis Masked by Hepatic Encephalopathy

Autor: Mark G. Carmichael, Jennifer C Thompson, Thomas B Buttolph, Jeffrey A. Hooke

Publikováno v: Military Medicine. 168:266-269

Tuberculous meningitis is a difficult diagnosis to make. The presenting symptoms, signs, and laboratory values are often nonspecific and can be attributed to other underlying conditions. Imaging and cerebrospinal fluid analysis can be more helpful. E

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8eb71358d7d3f91822ce17b96fb48de1
https://doi.org/10.1093/milmed/168.3.266

Zobrazit plný text záznamu

Central Nervous System Anaplastic Large Cell Lymphoma in an Adult: Successful Treatment with a Combination of Radiation and Chemotherapy

Autor: Mark G. Carmichael

Publikováno v: Military Medicine. 172:673-675

Anaplastic large cell lymphoma (ALCL) is 1 of 17 mature T cell neoplasms described by the World Health Organization. Primary central nervous system (PCNS) ALCL represents a distinct rare form of this family of non-Hodgkin lymphoma and discussions of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97dbbcc1d2efe54219ea6fc95d00a174
https://doi.org/10.7205/milmed.172.6.673

Zobrazit plný text záznamu

The Demonstration of Pulmonary Neuroendocrine Cell Hyperplasia with Tumorlets in a Patient with Chronic Cough and a History of Multiple Medical Problems

Autor: Lisa L. Zacher, Mark G. Carmichael

Publikováno v: Military Medicine. 170:439-441

A 58-year-old woman presented with chronic cough felt to be multifactorial secondary to asthma, gastroesophageal reflux disease, and chronic sinusitis. Additional medical history included obstructive sleep apnea, type 2 diabetes, and hypertension. Sh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aae01d7b2669129879b91ab84fb55230
https://doi.org/10.7205/milmed.170.5.439

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání